SUVRETTA CAPITAL MANAGEMENT LLC 13D and 13G filings for Kura Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-13 8:15 pm Sale |
2024-12-31 | 13G | Kura Oncology, Inc. KURA |
SUVRETTA CAPITAL MANAGEMENT LLC | 5,198,189 6.700% |
-2,274,154 (-30.43%) |
Filing |
| 2024-02-13 5:23 pm Purchase |
2023-12-31 | 13G | Kura Oncology, Inc. KURA |
SUVRETTA CAPITAL MANAGEMENT LLC | 7,472,343 9.990% |
1,095,528 (+17.18%) |
Filing |
| 2023-02-13 1:07 pm Purchase |
2022-12-31 | 13G | Kura Oncology, Inc. KURA |
SUVRETTA CAPITAL MANAGEMENT LLC | 6,376,815 9.300% |
2,804,396 (+78.50%) |
Filing |
| 2022-02-11 4:55 pm Purchase |
2021-12-31 | 13G | Kura Oncology, Inc. KURA |
SUVRETTA CAPITAL MANAGEMENT LLC | 3,572,419 5.400% |
69,000 (+1.97%) |
Filing |
| 2021-12-09 4:31 pm Purchase |
2021-11-29 | 13G | Kura Oncology, Inc. KURA |
SUVRETTA CAPITAL MANAGEMENT LLC | 3,503,419 5.300% |
3,503,419 (New Position) |
Filing |